NeuroSense Therapeutics (NRSN) Accumulated Expenses (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Accumulated Expenses came in at $1.2 million in Q4 2025, up 133.33% year-over-year from $498000.0 in Q4 2024, and up 133.33% quarter-over-quarter from $498000.0 in Q4 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Accumulated Expenses (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Accumulated Expenses across 6 years of filings, most recently posting $1.2 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 133.33% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 133.33% YoY), while the FY2025 annual figure was $1.2 million, up 133.33% from the prior year.
- Accumulated Expenses came in at $1.2 million for Q4 2025 at NeuroSense Therapeutics, up from $498000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.5 million in Q4 2023 to a low of $370000.0 in Q4 2022.
- Average Accumulated Expenses over 5 years is $790800.0, with a median of $498000.0 recorded in 2024.
- Year-over-year, Accumulated Expenses jumped 1427.59% in 2021 and sank 66.37% in 2024.
- Over 5 years, Accumulated Expenses stood at $443000.0 in 2021, then dropped by 16.48% to $370000.0 in 2022, then jumped by 300.27% to $1.5 million in 2023, then slumped by 66.37% to $498000.0 in 2024, then jumped by 133.33% to $1.2 million in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $1.2 million in Q4 2025, $498000.0 in Q4 2024, and $1.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 498,000.00 |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 370,000.00 |
| Dec 31, 2021 | 443,000.00 |
| Dec 31, 2020 | 29,000.00 |
API Access
NeuroSense Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();